Don Bell, University of Alabama Three groundbreaking studies pinpoint immune cells and proteins linked with the lingering condition — and suggest a possible cause. Immunologist Shokrollah Elahi led three recent…[...]
Read More
By Richard Sima The Washington Post Five years since the pandemic began, millions of people are still grappling with long COVID, even as new patients are joining their ranks. “Considering…[...]
Read More
Welcome to the AMA Update video and podcast. Today, we're talking about the latest on long COVID with Dr. Akiko Iwasaki, the Sterling Professor of Immunobiology at Yale University in…[...]
Read More
Noel C. Chan, Jeffrey I. Weitz, Blood (2020) 136 (4): 381–383.https://doi.org/10.1182/blood.2020007335 In this issue of Blood, Al-Samkari et al expand our understanding of thrombosis and bleeding risks and their predictors in hospitalized patients with…[...]
Read More
Mount Sinai Health System Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection-even when standard medical tests…[...]
Read More
Emerging 2025 research reveals a compelling link between Long COVID and urinary tract infections (UTIs), with implications for kidney damage, bladder dysfunction, and chronic urinary symptoms. This article synthesizes findings…[...]
Read More
New research from the Centre for Heart Lung Innovation (HLI) at St. Paul’s Hospital has identified inflammation in the lungs’ smallest airways as the cause of pulmonary long COVID. A…[...]
Read More
Abstract Background: There are currently seven coronaviruses that can infect humans and the latest addition to these viruses is the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Infection by SARS-CoV-2 is…[...]
Read More
For many people, a case of COVID-19 lasts a week or two. For millions of adults, though, symptoms stick around for weeks, months, even years. Long COVID is associated with…[...]
Read More
Gustavo Ferrer • Fernando Valerio-Pascua • César Alas-Pineda • et.al., DOI: 10.7759/cureus.82736 Abstract This review explores the therapeutic potential of intranasal chlorpheniramine maleate (iCPM) in managing both acute COVID-19 and Long COVID by integrating histamine H1 receptor…[...]
Read More